Licensed Post-Production Neutraceutical Administrator Suggested

Published: 2005-01-14 06:58:00

Updated: 2005-01-14 06:58:00

From the January 12th weekly discussion meeting held at the Korea Food and Drug Administration (KFDA), Professor Park Ki-whan of Chung-Ang University College of Industrial Science stressed that a regulatory implementation of licensed neutraceutical product administrator is necessary to promote th...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK